Table 2: Disease-specific characteristics.
|
Adults |
Children |
Mean age when respondent experienced first symptoms, years (n) |
16 (87) |
6 (289) |
Mean age of diagnosis, years (n)a |
17 (86) |
7 (287) |
Comorbidities, % (n) |
||
Asthma |
60% (52) |
44% (127) |
Allergies affecting the respondents the most, % (n) |
||
Allergies to animals (dogs, cats, horses, etc.) |
22% (19) |
23% (67) |
Allergies to pollen (grasses, weeds, trees, etc.) |
40% (35) |
54% (155) |
Allergies to house dust mites |
30% (26) |
22% (63) |
Other year-round allergies (cockroaches, mold etc.) |
8% (7) |
1% (4) |
Allergy symptoms, % (n) |
||
Stuffy nose, runny nose, sneezing or post-nasal drip |
87% (76) |
88% (254) |
Itchy, red or watery eyes |
78% (68) |
80% (230) |
Shortness of breath, chest tightness or pain, coughing or wheezing |
61% (53) |
59% (170) |
Itchy skin reactions, skin pain or redness of skin |
33% (29) |
37% (107) |
The symptoms are troublesome |
86% (75) |
90% (261) |
Monoallergic vs. Polyallergic, % (n) |
||
Monoallergic |
29% (25) |
24% (69) |
Polyallergic |
71% (62) |
76% (220) |
Medication use, % (n) |
||
Oral antihistamines |
80% (70) |
85% (246) |
Decongestants |
74% (64) |
78% (226) |
Nasal sprays and drops |
71% (62) |
73% (212) |
Eye drops |
64% (56) |
59% (170) |
Medication use every day (of those using the medication), % (n) |
||
Oral antihistamines |
21% (15) |
26% (63) |
Decongestants |
17% (11) |
18% (40) |
Nasal sprays and drops |
15% (9) |
17% (37) |
Eye drops |
14% (8) |
15% (26) |
aMean age of diagnosis is reported for respondents who have been diagnosed by a physician.